Pharmafile Logo
Pharmafocus logo
Advanced Search

UK

Showing 15 posts of 472 posts found.

imp_pologne2

NICE recommends Pierre Fabre’s Braftovi in BRAF V600-mutated advanced melanoma

January 21, 2019
Sales and Marketing Braftovi, Cancer, NICE, Pierre Fabre, UK, melanoma, pharma

Braftovi (encorafenib), a BRAF kinase inhibitor developed by Pierre Fabre, has been awarded approval in combination with Mektovi (binimetinib) by …

News

More young people surviving cancer in England, despite significant economic divide

January 17, 2019
Medical Communications, Research and Development Cancer, England, UK, health public health, oncology, young people

Mortality and five year survival rates in a range of different cancers among people aged 13-24 improved in England between …

News
perjeta-e1339339399552

Scotland recommends Roche’s Perjeta for HER2+ metastatic breast cancer

January 15, 2019
Manufacturing and Production, Sales and Marketing Breast cancer; Roche; Scotland, NHS, Perjeta, UK, pharma

Breast cancer patients in Scotland are set to receive an additional treatment option, as the Scottish Medicines Consortium announces its …

News
8mfhvyr9ncnz2pmccioqrzf1kgnqnvsr

UK-Japan partnership to see collaboration on incurable diseases, green technology and AI

January 11, 2019
Medical Communications AI, Japan, MRC, UK, international partnership, medicine, technology

A new partnership between the UK and Japan will see medical researchers and scientists join forces, in advancing research into …

News
astrazeneca_sign_sky

NICE recommends AstraZeneca’s Fasenra as third treatment option for severe asthma

January 4, 2019
Medical Communications, Sales and Marketing AstraZeneca, Fasenra, NHS, NICE, UK, asthma, pharma

It’s good news for both asthma patients and AstraZeneca after UK drug watchdog NICE saw fit to recommend the drugmaker’s …

News

NICE recommends Lenvima as alternative first-line therapy for advanced liver cancer

December 19, 2018
Research and Development, Sales and Marketing Lenvima, NICE, UK, liver cancer, pharma

UK drug watchdog NICE has revealed that it has recommended Eisai’s Lenvima (lenvatinib) for use on the NHS in England …

News

NHS overcrowding leads to ambulances being turned away

December 17, 2018
Sales and Marketing Hopsitals, NHS, UK, health, politics

NHS England’s first weekly report of the winter has revealed that 95% of hospital beds are occupied, while anything above …

News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

December 14, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Akorn, Boehringer, Novartis, Pfizer, Trump, UK, pharmafile, top 10

Business seemed to be the theme this week as Akorn’s acquisition of Fresenius fell through, while Boehringer announced a restructuring …

News
scotland-1761292_960_720

‘Significant’ health outcomes gap still exists in Scotland

December 14, 2018
Medical Communications NHS, Scotland, UK, health, inequality

There is a significant gap in health outcomes between the most and least deprived areas of Scotland, a Scottish government …

News

Data reveals November’s performance was worst on record for NHS

December 14, 2018
Medical Communications NHS, NHS England, UK, funding, investment, wait times

November saw the worst A&E performance on record, according to data released by NHS England. The number of patients who …

News
york-492566_960_720

York-based biotech expands premises after $2.2 million investment

December 14, 2018
Medical Communications UK, aptamer, biotech, funding, investment, york science park

The York-based Aptamer Group is set to expand its premises after securing $2.2 million in overseas investment in June of …

News
the_registered_head_office_of_santen_pharmaceutical_co

Scottish Medicines Consortium approves Verkazia for severe eye condition in children and adolescents

December 12, 2018
Research and Development, Sales and Marketing SMC, Santen, Scotland, UK, Verkazia, pharma, vernal keratoconjunctivitis

UK-based pharmaceutical firm Santen has announced that the Scottish Medicines Consortium has awarded approval to its eye drops emulsion Verkazia …

News
boites_de_xanax_et_dalprazolam_en_ce_moment_dans_les_pharmacies

Children being treated for problems with Xanax has increased more than 6 times since last year

December 10, 2018
Research and Development, Sales and Marketing UK, drug abuse, misuse, prescriptions, valium, xanax

The number of children being treated for problems with benzodiazepine drugs – which include prescription medicines Xanax and Valium – …

News
28246711066_52e38bc591_z

Health Secretary Matt Hancock says government may charter flights to deliver medicines in case of no-deal Brexit

December 7, 2018
Medical Communications Matt Hancock, NHS, UK, brexit, no-deal

British health secretary Matt Hancock has said the government is working out ways through which they could charter flights in …

News

UCB to invest £1 billion into UK R&D

December 6, 2018
Manufacturing and Production, Research and Development R&D, UCB, UK, brussels, investment, research

The Brussels-based multinational UCB will invest £1 billion into UK research and development, according to the government’s Life Sciences Sector …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026